Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure-Reference-Cited by-同舟云学术

Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure

Published:2017-11-17 Issue:34 Volume:24 Page:
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Cortese Francesca¹,Scicchitano Pietro²,Gesualdo Michele²,Ricci Gabriella²,Carbonara Santa²,Franchini Carlo³,Pia Schiavone Brigida Immacolata³,Corbo Filomena³,Ciccone Marco Matteo²

Affiliation:

1. Section of Cardiovascular Diseases, Department of Emergency and Organ, Transplantation, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy

2. Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation, University of Bari, Policlinico, Bari, Italy

3. Department of Pharmacy, University of Bari, Policlinico, Bari, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real World Outcomes of Direct Oral Anticoagulant in End Stage Kidney Disease on Dialysis;Journal of Korean Dialysis Access;2024-05-25

2. Pulmonary Thromboembolism Developed During Hospitalization: A Nationwide Retrospective Observational Study Using Claims Data;Cardiology and Therapy;2022-12-08

3. Comparison of Low and Full Dose Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Renal Dysfunction (from a National Registry);The American Journal of Cardiology;2021-11

4. Chronic mesenteric ischaemia masked by candida esophagitis in a renal transplant patient;BMJ Case Reports;2019-12